Explore the Science: Key Studies on GLP-1 Medications for Weight Loss Efficacy of Liraglutide in Non-Diabetic Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PMC, 2022
Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis Diabetes
The allegations, which are drawn from interviews with former employees, legal filings in court cases between Empower and former employees, FDA inspection reports and warning letters, and documents from state boards of pharmacy, show a dark side of the exploding market for GLP-1 weight loss shots and other drugs made by compounders
If youre concerned about your risk of developing additional metabolic diseases, such as diabetes, weight loss medications can help support your metabolic health so that you keep the weight off and improve relevant biomarkers
Researchers aren't exactly clear why the drug appears to work better in people with overweight or obesity (but not diabetes) compared to people with diabetes who also have overweight or obesity
Patients with orthostatic intolerance present with feelings of lightheadedness, dizziness, and brain fog